CN117871216A - Three-dimensional visualization method for glomerular fissure membrane in paraffin specimen - Google Patents
Three-dimensional visualization method for glomerular fissure membrane in paraffin specimen Download PDFInfo
- Publication number
- CN117871216A CN117871216A CN202410275143.7A CN202410275143A CN117871216A CN 117871216 A CN117871216 A CN 117871216A CN 202410275143 A CN202410275143 A CN 202410275143A CN 117871216 A CN117871216 A CN 117871216A
- Authority
- CN
- China
- Prior art keywords
- glomerular
- tissue
- membrane
- slit
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 117
- 230000001434 glomerular Effects 0.000 title claims abstract description 77
- 239000012188 paraffin wax Substances 0.000 title claims abstract description 39
- 238000007794 visualization technique Methods 0.000 title abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 40
- 238000007789 sealing Methods 0.000 claims abstract description 19
- 210000001519 tissue Anatomy 0.000 claims description 71
- VYLJAYXZTOTZRR-BTPDVQIOSA-N CC(C)(O)[C@H]1CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2CC[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3[C@@H](O)[C@H](O)[C@@]12C Chemical compound CC(C)(O)[C@H]1CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2CC[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3[C@@H](O)[C@H](O)[C@@]12C VYLJAYXZTOTZRR-BTPDVQIOSA-N 0.000 claims description 28
- 102100023195 Nephrin Human genes 0.000 claims description 28
- VYLJAYXZTOTZRR-UHFFFAOYSA-N hopane-6alpha,7beta,22-triol Natural products C12CCC3C4(C)CCCC(C)(C)C4C(O)C(O)C3(C)C1(C)CCC1C2(C)CCC1C(C)(O)C VYLJAYXZTOTZRR-UHFFFAOYSA-N 0.000 claims description 28
- 108010027531 nephrin Proteins 0.000 claims description 28
- 210000005084 renal tissue Anatomy 0.000 claims description 25
- 230000008439 repair process Effects 0.000 claims description 23
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 15
- 239000012099 Alexa Fluor family Substances 0.000 claims description 13
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 8
- 230000000903 blocking effect Effects 0.000 claims description 7
- 238000010790 dilution Methods 0.000 claims description 7
- 239000012895 dilution Substances 0.000 claims description 7
- 210000002966 serum Anatomy 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 241000283707 Capra Species 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000427 antigen Substances 0.000 abstract description 26
- 102000036639 antigens Human genes 0.000 abstract description 26
- 108091007433 antigens Proteins 0.000 abstract description 26
- 238000003384 imaging method Methods 0.000 abstract description 15
- 238000011862 kidney biopsy Methods 0.000 abstract description 11
- 230000004888 barrier function Effects 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 5
- 230000024924 glomerular filtration Effects 0.000 abstract description 5
- 238000001914 filtration Methods 0.000 abstract description 4
- 239000007850 fluorescent dye Substances 0.000 abstract description 3
- 230000036571 hydration Effects 0.000 abstract description 3
- 238000006703 hydration reaction Methods 0.000 abstract description 3
- 238000003125 immunofluorescent labeling Methods 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 239000000975 dye Substances 0.000 abstract 1
- 238000007634 remodeling Methods 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000004043 dyeing Methods 0.000 description 8
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 238000012744 immunostaining Methods 0.000 description 6
- 238000001000 micrograph Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 102100036037 Podocin Human genes 0.000 description 4
- 101710162479 Podocin Proteins 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 210000001736 capillary Anatomy 0.000 description 4
- 208000017169 kidney disease Diseases 0.000 description 4
- 230000000877 morphologic effect Effects 0.000 description 4
- 210000000557 podocyte Anatomy 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 3
- 238000000635 electron micrograph Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 201000001474 proteinuria Diseases 0.000 description 3
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical group C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000007894 caplet Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000007447 staining method Methods 0.000 description 2
- 238000003778 tissue fixation method Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000022461 Glomerular disease Diseases 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000010226 confocal imaging Methods 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003708 edge detection Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000005086 glomerual capillary Anatomy 0.000 description 1
- 231100000852 glomerular disease Toxicity 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000005732 intercellular adhesion Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention relates to the technical field of tissue fluorescent staining, in particular to a three-dimensional visualization method for glomerular slit membranes in paraffin specimens. The invention carries out dewaxing, hydration, antigen restoration and sealing treatment on the kidney biopsy tissue paraffin section, then sequentially carries out immune marking treatment by using a primary antibody and a secondary antibody, then carries out sealing, and can finish kidney glomerular slit membrane immunofluorescence staining, and then carries out imaging by a super-resolution laser confocal microscope. By using the method of the invention to dye and image the glomerular slit membrane, the three-dimensional structure of the glomerular slit membrane, including the cross-sectional structure and the continuous structure, can be visualized. Changes in the morphology of the slit membrane in the disease state and in the relaxed state can be observed by confocal images, providing direct evidence for assessing the function of the glomerular filtration barrier and exploring the characteristic changes in the slit membrane during remodeling of the filtration barrier.
Description
Technical Field
The invention relates to the technical field of tissue fluorescent staining, in particular to a three-dimensional visualization method for glomerular slit membranes in paraffin specimens.
Background
The glomerular fissure membrane (slit diabetes) is a special structure on glomerular capillary epithelial cells and has important physiological functions. It is located between the projections of capillary epithelial cells, in the form of a zipper, forming the last layer of filtration barrier, playing a vital role in the filtration function and selective permeability of the glomeruli. First, it allows the water and solutes in the blood to be filtered into the glomeruli and become part of the raw urine. The selective permeability enables the slit membrane to effectively prevent substances such as macromolecular proteins from passing through, thereby maintaining the osmotic pressure and ion balance of body fluid. Second, the glomerular fissure membrane also plays an important role in regulating glomerular filtration rate and hemodynamics. By adjusting the permeability and surface charge of the slit membrane, the kidney can dynamically adjust the filtration rate according to the needs of the organism so as to maintain the stable concentration of various components in blood. In addition, glomerular fissure membranes are involved in the development and progression of diseases such as glomerulonephritis and the like. In the disease state, the structure and function of the slit membrane may be damaged, resulting in the appearance of symptoms such as proteinuria, hematuria, and the like.
Glomerular fissure membranes are composed of a variety of proteins including nephrin and podocin. Nephrin is an important transmembrane protein, mainly present on the cell membrane of podocytes (podocytes) of the glomeruli. It combines with adjacent podocytes through its extracellular structure, forming an important component of the glomerular fissure membrane. The presence of Nephrin helps to maintain the structural integrity of the slit membrane while also participating in signaling and intercellular adhesion, which is critical to maintaining the normal function of the glomerular filtration barrier. On the other hand, podocin is a protein that interacts with nephrin, mainly on the cell membrane of podocytes. Podocin binds to nephrin to form an important protein complex that is critical to maintaining the structure and function of the glomerular filtration barrier. Overall, nephrin and podocin maintain the structural integrity and functional stability of the glomerular filtration barrier as an important component of the glomerular fissure membrane. Their abnormal expression or defective function may lead to the occurrence and development of glomerular diseases, and thus have great significance for normal physiological functions of glomeruli.
The width of the glomerulus fissure membrane is very tiny, usually in the range of 20-50 nanometers, and the glomerulus fissure membrane is observed to be a zipper-like continuous structure through a scanning electron microscope, but only a punctiform structure of a cross section can be observed through a clinical transmission electron microscope (the thickness is 50-70 nanometers), and the continuous form of the glomerulus fissure membrane cannot be seen; in addition, the structure of the slit membrane is tiny, the observation by a transmission electron microscope depends on the dyeing of osmium acid, and if the dyeing is lighter, the slit membrane is not easy to identify. Thus, although electron microscopy is a technique commonly used in clinic to view glomerular ultrastructures, there are the following limitations and disadvantages to the visualization of the slit membrane structure by it: 1. limitation of two-dimensional structure: the ultrathin section used for observation after electron microscope sample preparation is about 70nm, is limited by the angle of the section, and can only observe the cross section structure of the slit film, while the three-dimensional structure of the slit film is complex and continuous, like a zipper-like structure, and cannot be completely displayed in an ultrathin section image; 2. sample restriction: the method is limited by an electron microscope specimen, and an electron microscope ultrathin section usually only has 1-2 glomeruli, and 15-25 glomeruli are used for paraffin kidney biopsy tissue, so that the damage condition of a filter membrane cannot be comprehensively estimated; 3. challenges of sample processing: the steps of fixing an electron microscope sample, preparing a slice, dyeing and the like require high technical skills and complicated operations, and improper sample treatment such as undersize dyeing leads to insufficient dyeing of a slit membrane to influence the observation of a pathologist on the slit membrane; 4. clinical assessment was inadequate: because the slit membrane shown in the electron microscopy image is a cross-sectional structure, it is not possible to provide much information to a clinical pathologist in assessing the damage to the filter membrane in proteinuria patients, resulting in few observation subjects of the ultrastructure of current kidney biopsy puncture specimens involving the slit membrane.
Disclosure of Invention
In order to solve the problems, the invention provides a three-dimensional visualization method for glomerular slit membranes in paraffin specimens. The method provided by the invention can directly realize the observation of the morphology of the glomerular slit membrane of the kidney biopsy paraffin specimen under a confocal microscope after thermal repair treatment and dyeing, and comprises the observation of the area of the glomerulus and/or the length of the glomerular slit membrane.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides a method for assisting in observing the morphology of a glomerular fissure membrane, which comprises the following steps:
using thermal repair to treat the kidney tissue paraffin section, and sealing to obtain a sealed tissue section; the time for thermal restoration treatment of the tissue slices is 9-11 min, and the reagent for thermal restoration treatment of the tissue slices comprises EDTA;
incubating the blocked tissue sections with NEPHRIN antibody and ALEXA FLUOR 594-goat anti-mouse antibody in sequence, and sealing to obtain the sealed tissue sections;
placing the tissue slice of the sealing slice under a confocal microscope to observe the morphology of the glomerular fissure membrane; the glomerular slit membrane morphology includes an area of glomeruli and/or a length of glomerular slit membrane.
Preferably, the NEPHRIN antibody is available from the company Proteintech under the accession number 66970-1-Ig.
Preferably, the thermal repair process includes: and (3) placing the kidney tissue paraffin section into a reagent for thermal restoration treatment of the tissue section, and heating the kidney tissue paraffin section in a pressure cooker for 9-11 min by water.
Preferably, the NEPHRIN antibody and ALEXA FLUOR 594-goat anti-mouse antibody are diluted in PBS.
Preferably, the NEPHRIN antibody is diluted in a ratio of 1: 600-1: 1000;
the dilution ratio of the ALEXA FLUOR 594-goat anti-mouse antibody is 1: 200-1: 400.
preferably, the blocking reagent comprises goat serum with the volume concentration of 10%, and the blocking time is 50-60 min.
Compared with the prior art, the invention has the following beneficial effects:
(1) The method for staining the glomerular slit membrane has better antibody sensitivity and specificity, and can mark all glomerular slit membranes, thereby realizing the observation of a three-dimensional structure, including not only a cross section punctiform structure observed by a clinical transmission electron microscope specimen, but also a continuous structure observed by a scanning electron microscope in scientific research.
(2) Compared with the electron microscope specimen which needs extra tissues and samples, the method does not need extra specimens, can directly use the conventional paraffin embedded tissue section, uses indirect immunofluorescence to complete staining, and saves specimen drawing and sample preparation time.
(3) The method disclosed by the invention is simple in immunostaining process, is a common indirect immunostaining technology, and is low in requirement on technicians and high in feasibility.
(4) After the glomerulus slit membrane is dyed by the method provided by the invention, the renal specimen can be maximally utilized, and the damage condition of the glomerulus slit membrane can be comprehensively evaluated by incorporating all glomeruli.
(5) When the tissue slice dyed by the method provided by the invention is imaged, a confocal microscope is used to obtain enough resolution, so that the efficiency is improved, and the cost is saved.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings that are required to be used in the embodiments will be briefly described below.
FIG. 1 is a comparison of different antigen retrieval methods;
FIG. 2 is a graph comparing the repair times of different high pressure thermal antigens;
FIG. 3 is a graph comparing the results of fluorescent staining of primary antibody products;
FIG. 4 is a comparison of imaging effects from different tissue fixation methods and different imaging devices;
FIG. 5 is a graph showing the contrast of an imaging image and an electron microscope image of a healthy glomerular fissure membrane of a paraneoplastic kidney tissue, respectively, using the staining method of the present invention;
FIG. 6 is a graph showing the comparison of an imaging image and an electron microscope image of a glomerular slit membrane of a patient suffering from a remission stage of a micro-lesion nephropathy, and a graph showing measurement of the glomerular sphere area and slit membrane length;
FIG. 7 is a graph showing the comparison of an image of glomerular slit membranes of a patient with a micro-lesion nephropathy with an electron microscope image, respectively, using the staining method of the present invention.
Detailed Description
The invention provides a method for assisting in observing the morphology of a glomerular fissure membrane, which comprises the following steps:
using thermal repair to treat the kidney tissue paraffin section, and sealing to obtain a sealed tissue section; the time for thermal restoration treatment of the tissue slices is 9-11 min, and the reagent for thermal restoration treatment of the tissue slices comprises EDTA;
incubating the blocked tissue sections with NEPHRIN antibody and ALEXA FLUOR 594-goat anti-mouse antibody in sequence, and sealing to obtain the sealed tissue sections;
placing the tissue slice of the sealing slice under a confocal microscope to observe the morphology of the glomerular fissure membrane; the glomerular slit membrane morphology includes an area of glomeruli and/or a length of glomerular slit membrane.
The present invention preferably dewaxes and hydrates paraffin sections of kidney tissue. The kidney tissue paraffin section according to the present invention is preferably obtained by a conventional paraffin section preparation method, and the thickness of the kidney tissue paraffin section is preferably the thickness of a clinically conventional sample, more preferably 3 μm. The invention selects the slice thickness of the clinical routine sample, which not only saves sample drawing and sample preparing time, but also has good effect on antibody sensibility and immunostaining resolution of the slice with micron-sized thickness.
In the present invention, the dewaxing preferably comprises the steps of: primarily soaking the kidney tissue paraffin section by using dimethylbenzene; soaking the primarily soaked kidney tissue paraffin section for 30-50 min by using new dimethylbenzene; the primary soaking time is preferably 30-50 min, more preferably 40min; the time for re-soaking is preferably 30-50 min, more preferably 40min. The dewaxing method can completely dewax paraffin sections, avoids the antigen from being not exposed caused by insufficient dewaxing, and provides a good basis for subsequent dyeing.
In the invention, the hydration treatment method comprises the following steps: the dewaxed tissue slice is subjected to a first treatment for 10min by using alcohol with the volume concentration of 100%, the first treated tissue slice is subjected to a second treatment for 10min by using alcohol with the volume concentration of 100%, the second treated tissue slice is subjected to a third treatment for 5min by using alcohol with the volume concentration of 95%, the third treated tissue slice is subjected to a fourth treatment for 5min by using alcohol with the volume concentration of 95%, and the fourth treated tissue slice is subjected to a fifth treatment for 2min by using alcohol with the volume concentration of 80%. The hydration method can better reduce tissues to an in-vivo state, and avoid the problems of uneven dyeing, non-specific background coloring and the like.
After the tissue slice is hydrated, the invention uses thermal repair to treat the kidney tissue paraffin slice and seals the kidney tissue paraffin slice to obtain a sealed tissue slice. In the invention, the time for thermal repair treatment of the tissue slices is 9-11 min, preferably 10min; the thermal repair process preferably includes: placing the kidney tissue paraffin section into a reagent for heat repairing treatment of the tissue section, and heating the kidney tissue paraffin section by water in an autoclave; the pressure of the thermal repair treatment tissue slice is preferably 80-100 kilopascals; the agent for thermal restoration treatment of tissue slices comprises EDTA; the pH of the EDTA is preferably 9.0; the temperature of the enclosure is preferably room temperature; the blocking reagent preferably comprises goat serum with the volume concentration of 10%, and the blocking time is preferably 50-60 min, more preferably 55min. In the thermal repair treatment time, the morphology of the glomerular fissure membrane cannot be displayed when the treatment time is too short; the treatment time is too long and nonspecific staining occurs. According to the invention, through proper thermal repair treatment time, only one antigen repair is carried out, so that antigens can be completely exposed, and non-specific staining can not occur.
After obtaining the tissue slice subjected to the sealing treatment, the invention sequentially incubates the tissue slice subjected to the sealing treatment with NEPHRIN antibody and ALEXA FLUOR 594-goat anti-mouse antibody, and seals the tissue slice to obtain the tissue slice of the sealing piece. In the present invention, the NEPHRIN antibody and ALEXA FLUOR 594-goat anti-mouse antibody are preferably used after being diluted with PBS solution; the NEPHRIN antibody is preferably diluted in a ratio of 1: 600-1: 1000, further preferably 1: 800-1: 900, more preferably 1:800; the NEPHRIN antibody is used for incubating the tissue slice subjected to the sealing treatment preferably at the temperature of 4 ℃, and the incubation time is preferably 12-14 h, more preferably 12h; the dilution ratio of the ALEXA FLUOR 594-goat anti-mouse antibody is preferably 1: 200-1: 400, more preferably 1:300; the ALEXA FLUOR 594-goat anti-mouse antibody is preferably used for incubating the tissue section incubated by the NEPHRIN antibody for 0.5-1 h at room temperature, and the incubation time is more preferably 1h. In a specific embodiment of the invention, it is preferred that after treatment of the tissue sections with NEPHRIN antibody, the tissue sections are washed 3 times with PBS buffer for 3min each time, and then treated with ALEXA FLUOR 594-goat anti-mouse antibody. In the present invention, the NEPHRIN is preferably available from the company Proteintech under the accession number 66970-1-Ig. The NEPHRIN antibody selected by the invention can be used as a primary antibody for marking tissue sections, so that glomerular fissure membranes in normal states and all disease states can be stained and visualized.
In the present invention, the caplet used in the caplet is preferably DAPI (cat#d5942 Sigma). Before sealing, the tissue slice is preferably washed for 3 times with PBS buffer solution for 3min each time, so that the nonspecific adsorption secondary antibody is guaranteed to be cleaned, the nonspecific color development is reduced, the background is guaranteed to be clean, and the tissue slice is preserved in a dark place after sealing.
After obtaining the tissue slice of the sealing slice, the invention places the tissue slice of the sealing slice under a confocal microscope to observe the morphology of the glomerular fissure membrane; the glomerular slit membrane morphology includes an area of glomeruli and/or a length of glomerular slit membrane.
In the method for observing the morphology of the glomerular slit membrane, the confocal microscope is preferably used for imaging, the super-resolution confocal imaging is preferred for the adopted imaging mode, the nikon AX R with NSPARC equipment model is preferred, the 100×oil immersion objective NA1.4 is preferred for the image acquisition condition, the 163×163 μm image is acquired, the 0.3 μm single-layer thickness image is set, the continuous shooting is preferred, and the number of shooting layers is preferably 10.
In the invention, the photographed image is preferably subjected to image post-processing by using image processing software, wherein the image processing software is preferably NIS-Elements AR, and the specific operation is preferably deconvolution by using Lucy-Richardson, and the most preferably 5 times.
In the invention, the deconvoluted image is preferably subjected to maximum projection, and the obtained image can obtain a three-dimensional image of an in-situ slit membrane structure of the kidney biopsy puncture paraffin tissue.
In a specific embodiment of the invention, morphological features of the glomerular fissure membrane in the three-dimensional image are observed, including but not limited to the following morphological parameters: 1) Similarity between continuity and integrity of glomerular fissure membranes and morphology; 2) Length of glomerular fissure membrane per unit area. In a specific embodiment of the present invention, the measurement method preferably uses an ImageJ image processing software system to perform the measurement of the glomerular slit membrane morphological parameters.
The measurement method for the glomerular fissure membrane length per unit area in the three-dimensional image is preferably as follows: opening the picture using ImageJ software, and circling (Polygon selections) the glomerular target area; measuring the area of the selected region (analysis-measure), streaking (segmented line) along the glomerular fissure membrane, and measuring the segment (analysis-measure); the ratio of the obtained length to the area can reflect the damage degree of the glomerular fissure membrane. A smaller ratio of length/area represents more severe damage.
The immunofluorescence staining method provided by the invention can be used for visualizing the three-dimensional structure of the glomerular slit membrane of the paraffin specimen by combining confocal microscopy imaging, and comprises a cross-sectional structure and a continuous structure. Changes in the morphology of the slit membrane in the disease state and in the relaxed state can be observed by confocal images.
For further explanation of the present invention, the following describes in detail a method for visualizing the glomerular fissure membrane in paraffin specimens provided by the present invention, with reference to the accompanying drawings and examples, which should not be construed as limiting the scope of protection of the present invention.
Example 1
A method for immunofluorescence staining of glomerular fissure membranes, which comprises the following steps:
1. treatment prior to immunolabeling of paraffin sections of kidney biopsies:
1) Kidney biopsy tissue paraffin section: patient kidney biopsies were fixed using conventional 4.5% formalin and sectioned to a thickness of 3 μm after conventional paraffin embedding;
2) Dewaxing and hydrating: paraffin sections were sequentially passed through xylene and alcohol cylinders: xylene 40min,100% alcohol 10min,95% alcohol 5min,80% alcohol 2min, and then PBS washing 3 times for 3min each;
3) Antigen retrieval: the antigen repairing method is EDTA high-pressure repairing, and the specific method comprises the following steps: heating and boiling the autoclave, and then placing paraffin tissue slices into EDTA repair liquid (pH value is 9.0) of the autoclave, and heating the paraffin tissue slices to boiling; covering a pressure valve until the steam is sprayed for 10min;
4) Closing: blocking 10% goat serum at room temperature for 30min;
2. performing immune labeling treatment on paraffin section glomerular slit membranes:
1) An anti-treatment: dilution ratio 1 with PBS: 800 dilution of murine anti-human NEPHRIN antibody (designated antibody 3), incubation of tissue sections overnight at 4 ℃ using diluted antibody;
2) Secondary antibody treatment: tissue sections were washed 3 times with PBS 3min each, diluted 1 with PBS: 300 dilution of ALEXA FLUOR 594-goat anti-mouse antibody, incubation of tissue sections with diluted antibody at room temperature for 1h;
3) DAPI-encapsulation tablet encapsulation: the tissue sections were washed 3 times with PBS for 3min each, blocked (chemically stained) with DAPI-containing blocking agents, and stored protected from light after blocking.
Example 2
Unlike example 1, the antigen retrieval time was 9min, with the remaining steps unchanged.
Example 3
Unlike example 1, the antigen retrieval time was 11min, with the remaining steps unchanged.
Comparative example 1
The subsequent experimental procedure of example 1 was performed using kidney tissue frozen section 1; the preparation process of the frozen section 1 is as follows: the kidney puncture biopsy tissue is placed into an embedding mould with the OCT, precooled OCT is continuously added into the embedding mould, the tissue is completely covered, and the tissue is sliced in a frozen microtome, wherein the thickness of the tissue is about 5 mu m. Frozen section 1 was washed 3 times in PBS for 3min each, then sheep serum was blocked, and primary and secondary antibodies, isoparaffin tissue were added.
Comparative example 2
Unlike example 1, the antigen retrieval method was microwave EDTA retrieval, the remaining steps were unchanged; the microwave EDTA repairing method comprises the following steps: heating to boiling with 100W of microwave fire, taking out the beaker, placing the tissue slice into boiling EDTA repair liquid (pH value is 9.0), placing into the microwave oven again, reducing fire to 40W, heating for 10min, and naturally cooling.
Comparative example 3
Unlike example 1, the antigen retrieval method was citric acid high pressure retrieval, the remaining steps were unchanged; the method for repairing the citric acid under high pressure comprises the following steps: placing paraffin tissue slices into a citric acid restoration solution (pH value is 6.0) of the autoclave, and heating to boil; the pressure valve is covered until the vapor is sprayed for 5min.
Comparative example 4
Unlike example 1, the antigen retrieval was performed using 0.4% pepsin, specifically 100. Mu.l of 0.4% pepsin digest (ZLI-9013) was added dropwise to the tissue sections, the volume of addition was such that the tissue could be covered, and incubation was carried out for 30min at 37℃with the remaining steps unchanged.
Comparative example 5
Unlike example 1, the time for antigen retrieval was 5min, with the remaining steps unchanged.
Comparative example 6
Unlike example 1, the time for antigen retrieval was 15min, the remaining steps were unchanged.
Comparative example 7
Unlike example 1, the rabbit anti-human NEPHRIN antibody was replaced with antibody 1 at the time of primary antibody treatment, and antibody 1 was purchased from OriGene Technologie company under the accession number BP5030, and the corresponding secondary antibody was used, with the remaining steps unchanged.
Comparative example 8
Unlike example 1, the rabbit anti-human NEPHRIN antibody was replaced with antibody 2 at the time of primary antibody treatment, and antibody 2 was purchased from Merck company under the designation PRS2265, with the corresponding secondary antibody, and the remaining steps were unchanged.
Comparative example 9
Unlike example 1, the imaging apparatus was a general fluorescence microscope.
Test example 1
Placing the fluorescence-dyed sections of the example 1 and the comparative examples 1-8 under a 100-time common fluorescence microscope, and integrally evaluating the immunostaining condition of glomerular slit membranes to ensure that all the slit membranes of the glomerulus are fluorescence-positive; the slice is placed under a 100-fold confocal fluorescence microscope (meanwhile, comparative example 9) for shooting imaging, deconvolution treatment is carried out, and morphological characteristics of the glomerular slit membrane are observed and measured. The results are shown in fig. 1-4.
FIG. 1 is an image of paraneoplastic kidney tissue imaged with a 100-fold super-resolution confocal microscope using different antigen retrieval methods, wherein the scale of the left panel is 50 μm; the scale of the right detail drawing is 5 μm. As can be seen from fig. 1, the microwave high temperature EDTA repair (a) in fig. 1, the gastric enzyme repair (b) in fig. 1, the citric acid repair (c) in fig. 1), the slit membrane (SD) was stained positive, but the antigen was not fully exposed, the antigen was exposed by about 50% -70%, and in addition, the glomerular slit membrane structure was not etched out and could not be distinguished; example 1 of the present invention uses high pressure EDTA thermal repair (d in fig. 1) with 100% antigen exposure, the glomerular slit membrane structure was etched out easily discernable.
FIG. 2 is a comparison of paraneoplastic kidney tissue at various times during the autoclave repair, wherein the scale on the left panel is 5 μm; the scale of the right detail drawing is 1 μm. As can be seen from fig. 2, EDTA autoclave antigen repair for 5min (a in fig. 2), glomeruli were positive, partial slit membrane (SD) antigen exposure, about 40% of antigen exposure, but glomerular slit membrane structure was indistinguishable; EDTA autoclave antigen repair for 15min (b in FIG. 2), glomeruli were positive, all slit membrane antigens were exposed, but there was nonspecific staining, resulting in a blurred and indistinguishable glomerular slit membrane structure; example 1 of the present invention was heat-repaired using high pressure EDTA for 10min (c in fig. 2), with 100% antigen exposure, the glomerular fissure membrane structure was completely etched out, and the punctate structure (SD-a) and the continuous serpentine structure (SD-b) were clearly distinguished.
FIG. 3 is a comparative graph of immunolabeling of paraneoplastic kidney tissue using different antibody products, with the left large scale of 10 μm and the right detailed scale of 2 μm. As can be seen from fig. 3, the staining of antibody 1 (a in fig. 3) marks glomerular fissure membrane of glomeruli to some extent, but the fluorescence signal intensity is weak, and glomerular fissure membrane Structure (SD) cannot be completely etched; antibody 2 (b in fig. 3) can mark most of the slit membranes, the antigen marks about 80%, the specificity to the glomerular slit membranes is strong, but the slit membrane has poor structural continuity, only punctiform structures (SD-a) can be etched, and serpentine structures can not be etched; the NEPHRIN antibody (antibody 3, c in fig. 3) used in the present invention has good specificity and sensitivity to glomerular slit membrane markers, and the signals can be seen to be distributed along the capillary wall, and the punctiform morphology (SD-a) and the serpentine morphology (SD-b) of the glomerular slit membrane can be distinguished from each other by the signals.
Fig. 4 is a comparison of paraneoplastic kidney tissue using different tissue fixation methods and different imaging modalities. As can be seen from fig. 4, using frozen tissue (a in fig. 4), glomerular markers were positive, but slit membrane Structure (SD) morphology was poorly preserved; imaging paraffin tissue (b in fig. 4) after nephrin immunolabeling under a common fluorescence microscope can show the morphology of the slit membrane, but the outline is not clear enough; after imaging by a super-resolution confocal microscope (c in fig. 4), the complete slit membrane punctiform structure (SD-a) and serpentine structure (SD-b) can be displayed. The slit membrane structure observed by the transmission electron microscope (d in fig. 4) is located between adjacent foot processes, and is limited by the sample preparation and imaging modes, and one view can only display the slit membrane of the local capillary vessel wall.
Example 4
The renal small sphere area and the slit membrane length obtained in example 1 were measured in a specific manner comprising the steps of:
picture was opened using ImageJ software to delineate the area of glomeruli (d in fig. 6), toolbar-polygon selections, measure the area of the circled site, analyze-measure; the area of glomeruli can be obtained. Measuring the length of the slit film, firstly converting an image from RGB to a gray image (g in fig. 6), namely image-type-8-bit, then identifying the slit film through a plug-in of edge Detection (h in fig. 6), and clicking a measurement to obtain the length of the slit film.
Test example 2
The image of immunostaining and the electron microscope image of the ultrathin section of the healthy glomerular slit membrane obtained from the paraneoplastic renal tissue were respectively subjected to the method of example 1, and the morphology of the glomerular slit membrane was observed and the glomerular slit membrane length/area ratio was measured. The result is shown in FIG. 5, where b is a detailed view within the box in a.
As can be seen from fig. 5, the whole glomeruli can be displayed using a super-resolution confocal microscope, with an image size of 163 μm (long) ×163 μm (wide) ×2 μm (thick) of the slit membrane (a in fig. 5), and thus the 3D structure of the slit membrane can be displayed including not only the dot-like structure (SD-a, f in fig. 5, and g in fig. 5) visible in the electron microscope image, but also the continuous linear serpentine structure (SD-b, D in fig. 5); transmission electron microscopy (c in fig. 5), with an image size of 18 μm (length) x 14 μm (width) x 70nm (thickness), a slit membrane Structure (SD) was located between adjacent foot processes (f in fig. 5 and g in fig. 5), limited to the manner of sample preparation and imaging, and only slit membranes of local capillary walls were displayed. The ratio of the length to the area of the slit film was 0.61 μm -1 。
Test example 3
Kidney biopsies from patients with minimal lesion kidney disease in remission were immunostained and transmission electron microscopy-sampled electron microscopy pictures of ultrathin sections, respectively, by the method of example 1, and the morphology of glomerular slit membranes was observed and the glomerular slit membrane length/area ratio was measured. The result is shown in fig. 6, where b is a detailed view within the box in a and f is an enlarged view within the box in c.
As can be seen from fig. 6, the whole glomeruli (a in fig. 6) can be displayed under a super-resolution confocal microscope at 100 times, the continuous morphology of the slit membrane (SD-b, e in fig. 6) can be seen in an enlarged view, and the electron microscopy image is limited to the slice thickness, i.e., only 70nm, and thus the cross section of the continuous morphology (f in fig. 6) can be seen even. Slit membraneThe length/area ratio was 0.54. Mu.m -1 。
Test example 4
Kidney biopsies from patients with micro-lesions in the period of kidney disease were immunostained and transmission electron microscopy-sampled in an electron microscope image of ultrathin sections, respectively, by the method of example 1, and the morphology of glomerular slit membrane was observed and the glomerular slit membrane length/area ratio was measured. The result is shown in fig. 7, where b is a detailed view within the box in a and f is an enlarged view within the box in c.
As can be seen from fig. 7, the entire glomeruli (a in fig. 7) can be visualized using a super-resolution confocal microscope at 100 x, and the enlarged view can reveal various morphologies of the slit membrane, including the punctiform structures under cross-section (SD-a, d in fig. 7), and different continuous serpentine morphologies (SD-b, e in fig. 7 and g in fig. 7), which are different from paraneoplastic kidney tissue (d in fig. 5) and remission tissue (e in fig. 6). Only the punctiform morphology of the slit film (f in FIG. 7) can be seen in the electron microscopy image. The ratio of the length to the area of the slit film was 0.44 μm -1 。
In conclusion, compared with the method, the glomerular slit membrane is dyed, and the 3D structure of the glomerular slit membrane, including punctate morphology and continuous structure, can be clearly displayed. The morphology of the slit membrane in proteinuria disease presents a different morphology; whereas after treatment, the slit membrane has been reconstructed and the morphology tends to paraneoplastic kidney tissue. On one hand, the traditional concept and the technical barrier that the morphology of the glomerular fissure membrane can only be observed under an electron microscope are broken; on the other hand, the structure of glomerular fissure membranes of all kidney biopsy puncture tissues can be examined, so that a pathologist can evaluate the damage of the filter membranes more comprehensively; in addition, the method is a common indirect immunostaining technology, is simple to operate, has low requirements on technicians, and has high feasibility.
Although the foregoing embodiments have been described in some, but not all, embodiments of the invention, it should be understood that other embodiments may be devised in accordance with the present embodiments without departing from the spirit and scope of the invention.
Claims (6)
1. A method for aiding in the observation of glomerular fissured membrane morphology comprising the steps of:
using thermal repair to treat the kidney tissue paraffin section, and sealing to obtain a sealed tissue section; the time for thermal restoration treatment of the tissue slices is 9-11 min, and the reagent for thermal restoration treatment of the tissue slices comprises EDTA;
incubating the blocked tissue sections with NEPHRIN antibody and ALEXA FLUOR 594-goat anti-mouse antibody in sequence, and sealing to obtain the sealed tissue sections;
placing the tissue slice of the sealing slice under a confocal microscope to observe the morphology of the glomerular fissure membrane; the glomerular slit membrane morphology includes an area of glomeruli and/or a length of glomerular slit membrane.
2. The method of claim 1, wherein the NEPHRIN antibody is purchased from proteontech under the accession number 66970-1-Ig.
3. The method of claim 1, wherein the thermal repair process comprises: and (3) placing the kidney tissue paraffin section into a reagent for thermal restoration treatment of the tissue section, and heating the kidney tissue paraffin section in a pressure cooker for 9-11 min by water.
4. The method of claim 1, wherein the NEPHRIN antibody and ALEXA FLUOR 594-goat anti-mouse antibody are used after dilution with PBS solution.
5. The method of claim 4, wherein the NEPHRIN antibody is diluted in a ratio of 1: 600-1: 1000;
the dilution ratio of the ALEXA FLUOR 594-goat anti-mouse antibody is 1: 200-1: 400.
6. the method of claim 1, wherein the blocking reagent comprises goat serum at a concentration of 10% by volume for 50-60 min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410275143.7A CN117871216B (en) | 2024-03-12 | Three-dimensional visualization method for glomerular fissure membrane in paraffin specimen |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410275143.7A CN117871216B (en) | 2024-03-12 | Three-dimensional visualization method for glomerular fissure membrane in paraffin specimen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117871216A true CN117871216A (en) | 2024-04-12 |
| CN117871216B CN117871216B (en) | 2024-06-04 |
Family
ID=
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102292434A (en) * | 2008-11-04 | 2011-12-21 | 弗雷森纽斯医疗护理德国有限责任公司 | An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney |
| CN105087467A (en) * | 2015-08-30 | 2015-11-25 | 中国医学科学院基础医学研究所 | Preparation method of kidney sertoli cells and special mediums thereof |
| CN106999547A (en) * | 2014-07-24 | 2017-08-01 | 欧蒙医学诊断技术有限公司 | Method and kit for monitoring membranous nephropathy |
| WO2020014208A1 (en) * | 2018-07-09 | 2020-01-16 | Yale University | Camk4 inhibitors for restoration of podocyte function in kidney disease |
| US20200049698A1 (en) * | 2017-04-27 | 2020-02-13 | Ernst-Moritz-Arndt-Universitat Greifswald | Diagnostic tool to determine podocyte foot process effacement |
| CN113543814A (en) * | 2019-01-18 | 2021-10-22 | 布里斯托尔大学 | AAV gene therapy for the treatment of nephrotic syndrome |
| US20230393147A1 (en) * | 2020-10-22 | 2023-12-07 | The Brigham And Women’S Hospital, Inc. | Methods for identifying and treating antibody-mediated acquired primary or recurrent idiopathic nephrotic syndrome |
| CN117629711A (en) * | 2023-12-05 | 2024-03-01 | 中日友好医院(中日友好临床医学研究所) | Semi-automatic foot cell podophyllum morphological parameter measurement method |
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102292434A (en) * | 2008-11-04 | 2011-12-21 | 弗雷森纽斯医疗护理德国有限责任公司 | An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney |
| CN106999547A (en) * | 2014-07-24 | 2017-08-01 | 欧蒙医学诊断技术有限公司 | Method and kit for monitoring membranous nephropathy |
| CN105087467A (en) * | 2015-08-30 | 2015-11-25 | 中国医学科学院基础医学研究所 | Preparation method of kidney sertoli cells and special mediums thereof |
| US20200049698A1 (en) * | 2017-04-27 | 2020-02-13 | Ernst-Moritz-Arndt-Universitat Greifswald | Diagnostic tool to determine podocyte foot process effacement |
| WO2020014208A1 (en) * | 2018-07-09 | 2020-01-16 | Yale University | Camk4 inhibitors for restoration of podocyte function in kidney disease |
| CN113543814A (en) * | 2019-01-18 | 2021-10-22 | 布里斯托尔大学 | AAV gene therapy for the treatment of nephrotic syndrome |
| US20230393147A1 (en) * | 2020-10-22 | 2023-12-07 | The Brigham And Women’S Hospital, Inc. | Methods for identifying and treating antibody-mediated acquired primary or recurrent idiopathic nephrotic syndrome |
| CN117629711A (en) * | 2023-12-05 | 2024-03-01 | 中日友好医院(中日友好临床医学研究所) | Semi-automatic foot cell podophyllum morphological parameter measurement method |
Non-Patent Citations (6)
| Title |
|---|
| DAVID UNNERSJÖ-JESS等: "Three-Dimensional Super-Resolved Imaging of Paraffin-Embedded Kidney Samples", KIDNEY360, vol. 3, no. 3, 31 March 2022 (2022-03-31), pages 446 - 454 * |
| FLORIAN SIEGERIST 等: "Structured illumination microscopy and automatized image processing as a rapid diagnostic tool for podocyte effacement", SCIENTIFIC REPORTS, no. 7, 13 September 2017 (2017-09-13), pages 1 - 11 * |
| KOBAYASHI, R等: "Expression of Nephrin, Podocin, alpha-Actinin-4 and alpha 3-Integrin in Canine Renal Glomeruli", JOURNAL OF COMPARATIVE PATHOLOGY, vol. 145, no. 2, 31 October 2011 (2011-10-31), pages 220 - 225 * |
| 刘海泉等: "膜性肾病肾活检组织中nephrin和podocin表达改变及其意义", 肾脏病与透析肾移植杂志, vol. 18, no. 4, 31 August 2009 (2009-08-31), pages 318 - 321 * |
| 安蔚 等: "肾病综合征患者肾小球中nephrin的表达意义", 中国误诊学杂志, no. 05, 31 May 2005 (2005-05-31), pages 816 - 818 * |
| 秦晓松 等: "在笼型蛋白和脂筏介导的两种内吞途径中nephrin的磷酸化修饰动力学不同", 中国生物化学与分子生物学报, vol. 26, no. 09, 30 September 2010 (2010-09-30), pages 847 - 853 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chung et al. | Use of ex vivo confocal scanning laser microscopy during Mohs surgery for nonmelanoma skin cancers | |
| Sugimoto et al. | What is the nature of pancreatic consistency? Assessment of the elastic modulus of the pancreas and comparison with tactile sensation, histology, and occurrence of postoperative pancreatic fistula after pancreaticoduodenectomy | |
| Puliatti et al. | Ex vivo fluorescence confocal microscopy: the first application for real‐time pathological examination of prostatic tissue | |
| Megens et al. | Two-Photon Microscopy of Vital Murine Elastic and Muscular ArteriesCombined Structural and Functional Imaging with Subcellular Resolution | |
| JP5410274B2 (en) | How to characterize an organization | |
| KR20080016583A (en) | Systems, processes and software arrangements for evaluating information associated with an anatomical structure by an optical coherence ranging technique | |
| Chu et al. | Microalterations of Esophagus in Patients With Non-Erosive Reflux Disease: In-VivoDiagnosis by Confocal Laser Endomicroscopy and Its Relationship With Gastroesophageal Reflux | |
| EP2962280A1 (en) | Automatic measurement of lesions on medical images | |
| Gareau et al. | Rapid screening of cancer margins in tissue with multimodal confocal microscopy | |
| Jain et al. | Rapid evaluation of fresh ex vivo kidney tissue with full-field optical coherence tomography | |
| Richardson et al. | Redefining 3Dimensional placental membrane microarchitecture using multiphoton microscopy and optical clearing | |
| Zhang et al. | IVIM with fractional perfusion as a novel biomarker for detecting and grading intestinal fibrosis in Crohn’s disease | |
| Ohno et al. | Pulmonary MR imaging with ultra-short TEs: utility for disease severity assessment of connective tissue disease patients | |
| Chou et al. | Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study | |
| Ge et al. | Feasibility and reproducibility of T2 mapping and DWI for identifying malignant lymph nodes in rectal cancer | |
| He et al. | Toward surface quantification of liver fibrosis progression | |
| Goncalves et al. | Probe-based confocal laser endomicroscopy in detecting malignant lesions of vocal folds | |
| TW201942869A (en) | Image synthesis method for biological sample and optical system using the same including an image inputting step, an image conversion step, a fusion operation step and a semi-H&E image outputting step | |
| Grieve et al. | A feasibility study of full-field optical coherence tomography for rapid evaluation of EUS-guided microbiopsy specimens | |
| Li et al. | Label-free multiphoton imaging to assess neoadjuvant therapy responses in breast carcinoma | |
| CN117871216B (en) | Three-dimensional visualization method for glomerular fissure membrane in paraffin specimen | |
| Hu et al. | Value of MR diffusion imaging in hepatic fibrosis and its correlations with serum indices | |
| CN117871216A (en) | Three-dimensional visualization method for glomerular fissure membrane in paraffin specimen | |
| Hutson et al. | Impact of tissue preservation on collagen fiber architecture | |
| Rueter et al. | Reflectance confocal microscopy for noninvasive examination of nonmelanocytic tumors and virus‐associated skin lesions in organ transplant recipients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant |